FDA: Repackaged Avastin Caused Eye Infections in Florida

The FDA has issued an alert that repackaged intravitreal injections of the drug Avastin have caused at least a dozen serious eye infections in the Miami area, according to an FDA news release.

 

The Florida Department of Health notified the FDA of a cluster of streptococcus endophthalmitis infections in three clinics, following intravitreal injection of the repackaged Avastin.

 

The tainted injections were traced to a pharmacy in Hollywood, Fla.

 

Related Articles on FDA Alerts:

FDA Warns Healthcare Professionals to Stop Using Claris IV Bags

Hospira Expands Recall of Propofol and Liposyn

Commentary on Safety Concerns Regarding Fresenius Propofol From Anesthesiologist Daniel Van Riper


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast